{"id":167445,"date":"2026-08-14T23:18:14","date_gmt":"2026-08-14T23:18:14","guid":{"rendered":"https:\/\/1cliqueconsultancy.com\/?p=167445"},"modified":"2026-08-14T23:18:14","modified_gmt":"2026-08-14T23:18:14","slug":"genotropin-16-pfizer-sve-sto-trebate-znati-o-doziranju","status":"publish","type":"post","link":"https:\/\/1cliqueconsultancy.com\/index.php\/2026\/08\/14\/genotropin-16-pfizer-sve-sto-trebate-znati-o-doziranju\/","title":{"rendered":"Genotropin 16 Pfizer: Sve \u0161to trebate znati o doziranju"},"content":{"rendered":"

Genotropin je lijek koji sadr\u017ei rekombinantni hormon rasta (rhGH) i \u010desto se koristi za lije\u010denje stanja povezanih s nedostatkom hormona rasta. Pfizerov proizvod Genotropin 16 je specijalno formuliran da pru\u017ei precizno doziranje za terapijske potrebe. U nastavku donosimo osnovne informacije o doziranju i upotrebi ovog va\u017enog lijeka.<\/p>\n

https:\/\/storeonline.blenastor.com\/wordpress\/2026\/08\/08\/genotropin-16-pfizer-sve-sto-trebate-znati-o-doziranju\/<\/a><\/p>\n

Osnovne informacije o doziranju<\/h2>\n

Pravilno doziranje Genotropina je klju\u010dno za postizanje optimalnih rezultata lije\u010denja. Doza \u0107e se razlikovati ovisno o pacijentovim potrebama i preporukama lije\u010dnika.<\/p>\n

Preporu\u010dene doze<\/h2>\n
    \n
  1. Djeca s niskim rastom:<\/strong> Preporu\u010dena doza iznosi izme\u0111u 0,02 i 0,03 mg\/kg tjelesne te\u017eine, primjenjuje se jednom dnevno ili 3 puta tjedno.<\/li>\n
  2. Odrasli s nedostatkom hormona rasta:<\/strong> U po\u010detku se obi\u010dno propisuje doza od 0,2 mg dnevno, a zatim se doza mo\u017ee pove\u0107ati prema potrebama pacijenta.<\/li>\n
  3. Pacijenti s Turnerovim sindromom:<\/strong> U ovom slu\u010daju, doza se prilago\u0111ava prema rastu i tjelesnoj te\u017eini, ali obi\u010dno se kre\u0107e oko 0,3 mg\/kg tjelesne te\u017eine.<\/li>\n<\/ol>\n

    Kako primijeniti Genotropin?<\/h2>\n

    Genotropin se obi\u010dno primjenjuje injekcijom ispod ko\u017ee (subkutano). Va\u017eno je da pacijenti nau\u010de pravilnu tehniku injekcije kako bi izbjegli komplikacije. Preporu\u010duje se primjena u predjelu trbuha ili bedara.<\/p>\n

    Zavr\u0161ne napomene<\/h2>\n

    Svako lije\u010denje Genotropinom treba se provoditi pod strogim nadzorom lije\u010dnika koji \u0107e pratiti napredak i eventualno prilagoditi doze. Pravilno doziranje i oblika terapije mogu zna\u010dajno utjecati na uspje\u0161nost lije\u010denja. Uvijek se pridr\u017eavajte uputa zdravstvenog radnika i ne mijenjajte dozu bez konzultacije.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Genotropin je lijek koji sadr\u017ei rekombinantni hormon rasta (rhGH) i \u010desto se koristi za lije\u010denje stanja povezanih s nedostatkom hormona rasta. Pfizerov proizvod Genotropin 16 je specijalno formuliran da pru\u017ei precizno doziranje za terapijske potrebe. U nastavku donosimo osnovne informacije o doziranju i upotrebi ovog va\u017enog lijeka. https:\/\/storeonline.blenastor.com\/wordpress\/2026\/08\/08\/genotropin-16-pfizer-sve-sto-trebate-znati-o-doziranju\/ Osnovne informacije o doziranju Pravilno doziranje Genotropina …<\/p>\n

    Genotropin 16 Pfizer: Sve \u0161to trebate znati o doziranju<\/span> Read More »<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/posts\/167445"}],"collection":[{"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/comments?post=167445"}],"version-history":[{"count":1,"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/posts\/167445\/revisions"}],"predecessor-version":[{"id":167446,"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/posts\/167445\/revisions\/167446"}],"wp:attachment":[{"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/media?parent=167445"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/categories?post=167445"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/1cliqueconsultancy.com\/index.php\/wp-json\/wp\/v2\/tags?post=167445"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}